- Home
- CPBI vs ABOS Comparison
CPBI vs ABOS Comparison
Compare CPBI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- ABOS
- Stock Information
- Founded
- CPBI 2023
- ABOS 1996
- Country
- CPBI United States
- ABOS United States
- Employees
- CPBI N/A
- ABOS N/A
- Industry
- CPBI
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- ABOS Health Care
- Exchange
- CPBI Nasdaq
- ABOS Nasdaq
- Market Cap
- CPBI 57.1M
- ABOS 66.6M
- IPO Year
- CPBI N/A
- ABOS 2021
- Fundamental
- Price
- CPBI $14.83
- ABOS $0.98
- Analyst Decision
- CPBI
- ABOS Strong Buy
- Analyst Count
- CPBI 0
- ABOS 3
- Target Price
- CPBI N/A
- ABOS $7.33
- AVG Volume (30 Days)
- CPBI 6.1K
- ABOS 213.3K
- Earning Date
- CPBI 01-01-0001
- ABOS 05-13-2025
- Dividend Yield
- CPBI N/A
- ABOS N/A
- EPS Growth
- CPBI 29.70
- ABOS N/A
- EPS
- CPBI 1.62
- ABOS N/A
- Revenue
- CPBI $18,546,000.00
- ABOS N/A
- Revenue This Year
- CPBI N/A
- ABOS N/A
- Revenue Next Year
- CPBI N/A
- ABOS N/A
- P/E Ratio
- CPBI $9.17
- ABOS N/A
- Revenue Growth
- CPBI 13.73
- ABOS N/A
- 52 Week Low
- CPBI $9.96
- ABOS $0.86
- 52 Week High
- CPBI $15.50
- ABOS $3.92
- Technical
- Relative Strength Index (RSI)
- CPBI 52.99
- ABOS 42.74
- Support Level
- CPBI $14.70
- ABOS $0.96
- Resistance Level
- CPBI $14.77
- ABOS $1.13
- Average True Range (ATR)
- CPBI 0.06
- ABOS 0.09
- MACD
- CPBI 0.02
- ABOS 0.00
- Stochastic Oscillator
- CPBI 67.39
- ABOS 14.26
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.